The dialysis industry faces another expensive lobbying year in California, where the Assembly Health Committee has passed a bill that would cap dialysis reimbursement.

The legality of CMS approval of New Hampshire's Medicaid work requirement will be decided by the same judge who blocked Kentucky's waiver.

Device and software maker Zoll Medical said the breach occurred during a recent service migration.

Florida's two legislative chambers are offering two different versions of certificate-of-need overhaul—showcasing the dilemma of states in implementing Washington-backed policy.

The drug will cost $34,000 without insurance, plus costs for staying in a hospital or infusion center.

As part of its long-awaited proposed rule on interoperability, the CMS wants industry feedback on how to give post-acute providers incentives to adopt EHRs—largely attributing the sector’s lag to lack of federal incentives.

Inpatient psychiatric facilities must abide by outmoded and inconsistently applied regulations that pile up costs, a new industry report says.

New payment programs that include both upside and downside risk seem perpetually stuck in a state of delay, researchers said.

The lawsuit against AbbVie targets Humira's patents, which protect the blockbuster drug from U.S. competition. Congress has ramped up scrutiny of the entire drug patent system.

Insurance plans should be ready to take a short-term financial hit to achieve savings from biosimilars, FDA Commissioner Dr. Scott Gottlieb advised.

New Hanover Regional Medical Center in Wilmington, N.C., recently hired a dietitian to visit malnourished patients at their homes to address the barriers they face to eating healthy.

Financial experts say not-for-profit health systems this year are more likely to consider derivative transactions to try to lower financing costs now that tax-exempt advance refunding is off the table.